Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Difundir a palavra, não o vírus

Comunicado de Imprensa | Nirsevimab protegeu significativamente as crianças contra a infeção pelo RSV no ensaio de Fase 3

Comunicado de Imprensa | VigiRSV: recém-criada Rede Nacional de Vigilância para o principal responsável por infeções respiratórias em crianças com menos de 2 anos de idade

Comunicado de Imprensa | VigiRSV: recém-criada Rede Nacional de Vigilância para o principal responsável por infeções respiratórias em crianças com menos de 2 anos de idade

A Sanofi lança a 1ª edição da On-Immunization Academy

Agenda Adam

Keeping your patients BP control during Ramadan

Closing the Gap for Women's Heart Health

In conjunction with Women's Heart Day, we are honoured to have 4 eminent speakers from Singapore & Malaysia to share with us on how to increase women’s heart health awareness where women have a near 2-fold increase risk of bleeding with men, and how to manage ACS for high bleeding risk among women.

Better control better life

CHAMP webinar 2023

QUEST publication

The full publication is available for the Quest study - a phase 3, randomised, double-blind, placebo controlled, parallel-group study in patients aged ≥12 years with uncontrolled moderate-to-severe asthma.1

Quest, Venture, and Traverse (DRI12544) Clinical Studies

The Clinical Trials page from Sanofi Australia provides comprehensive information about the company's commitment to advancing medical research through clinical studies.